Literature DB >> 12727790

Nitric oxide induces cyclooxygenase expression and inhibits cell growth in colon cancer cell lines.

Qiang Liu1, S T F Chan, Ratha Mahendran.   

Abstract

The role of nitric oxide (NO) in colon cancer remains controversial. Inducible nitric oxide synthase (iNOS) has been reported to be up regulated and down regulated in colorectal cancer in both animal models and patient tissue samples. Cyclooxygenase-2 (COX-2) is important in colorectal carcinogenesis but its relationship with NO has never been studied in colon cancer. Three colon cancer cell lines (HCA7, HT29 and HCT116) with different COX-2 expression and activities were used to study the effect of the NO donor, S-nitrosoglutathione (GSNO). The effects of GSNO (10-500 micro M) on cell growth, PGE(2) production, COX-1/COX-2 protein expression and cell-cycle distribution were evaluated. GSNO increased PGE(2) production and induced COX-1 and COX-2 protein expression in a dose- and time-dependent manner. Higher concentrations of GSNO also inhibited cell growth and induced apoptosis in all three cell lines, regardless of their COX-2 expression/activities. Inhibition of PGE(2) production did not further improve the inhibitory effect of GSNO.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12727790     DOI: 10.1093/carcin/bgg014

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  20 in total

1.  Somatostatin inhibits colon cancer cell growth through cyclooxygenase-2 downregulation.

Authors:  R Colucci; C Blandizzi; N Ghisu; T Florio; M Del Tacca
Journal:  Br J Pharmacol       Date:  2008-06-30       Impact factor: 8.739

2.  The role of NAG-1/GDF15 in the inhibition of intestinal polyps in APC/Min mice by sulindac.

Authors:  Xingya Wang; Philip J Kingsley; Larry J Marnett; Thomas E Eling
Journal:  Cancer Prev Res (Phila)       Date:  2011-01

3.  Nitric oxide: Friend or Foe in Cancer Chemotherapy and Drug Resistance: A Perspective.

Authors:  Birandra K Sinha
Journal:  J Cancer Sci Ther       Date:  2016-10-28

Review 4.  Inducible Nitric Oxide Synthase in the Carcinogenesis of Gastrointestinal Cancers.

Authors:  Graciele Almeida de Oliveira; Robert Y S Cheng; Lisa A Ridnour; Debashree Basudhar; Veena Somasundaram; Daniel W McVicar; Hugo Pequeno Monteiro; David A Wink
Journal:  Antioxid Redox Signal       Date:  2016-10-31       Impact factor: 8.401

5.  Expression of COX-2, iNOS, p53 and Ki-67 in gastric mucosa-associated lymphoid tissue lymphoma.

Authors:  Hong-Ling Li; Bing-Zhong Sun; Fu-Cheng Ma
Journal:  World J Gastroenterol       Date:  2004-07-01       Impact factor: 5.742

Review 6.  NO-donating NSAIDs and cancer: an overview with a note on whether NO is required for their action.

Authors:  Basil Rigas; Jennie L Williams
Journal:  Nitric Oxide       Date:  2008-04-29       Impact factor: 4.427

Review 7.  Glutathione analogues in cancer treatment.

Authors:  David Hamilton; Gerald Batist
Journal:  Curr Oncol Rep       Date:  2004-03       Impact factor: 5.075

8.  Correlation between inducible nitric oxide synthase and cyclooxygenase-2 expression in human colorectal adenocarcinoma: a cross-sectional study.

Authors:  Peiman Habibollahi; Mostafa Jamshidiha; Nasser E Daryani; Issa Jahanzad; Mohammad H Ghahremani; Seyed Nasser Ostad
Journal:  Pathol Oncol Res       Date:  2010-01-13       Impact factor: 3.201

9.  Aberrant up-regulation of iNOS/NO system is correlated with an increased abundance of Foxp3+ cells and reduced effector/memory cell markers expression during colorectal cancer: immunomodulatory effects of cetuximab combined with chemotherapy.

Authors:  Sarra Benkhelifa; Hayet Rafa; Said Belhadef; Hayat Ait-Kaci; Oussama Medjeber; Mourad Belkhelfa; Sabah Hetit; Sonia Ait-Younes; Yvan De Launoit; Olivier Moralès; Hassen Mahfouf; Nadira Delhem; Chafia Touil-Boukoffa
Journal:  Inflammopharmacology       Date:  2019-01-24       Impact factor: 4.473

Review 10.  A multi-targeted approach to suppress tumor-promoting inflammation.

Authors:  Abbas K Samadi; Alan Bilsland; Alexandros G Georgakilas; Amedeo Amedei; Amr Amin; Anupam Bishayee; Asfar S Azmi; Bal L Lokeshwar; Brendan Grue; Carolina Panis; Chandra S Boosani; Deepak Poudyal; Diana M Stafforini; Dipita Bhakta; Elena Niccolai; Gunjan Guha; H P Vasantha Rupasinghe; Hiromasa Fujii; Kanya Honoki; Kapil Mehta; Katia Aquilano; Leroy Lowe; Lorne J Hofseth; Luigi Ricciardiello; Maria Rosa Ciriolo; Neetu Singh; Richard L Whelan; Rupesh Chaturvedi; S Salman Ashraf; H M C Shantha Kumara; Somaira Nowsheen; Sulma I Mohammed; W Nicol Keith; William G Helferich; Xujuan Yang
Journal:  Semin Cancer Biol       Date:  2015-05-05       Impact factor: 15.707

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.